日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery and Optimization of LATS1 and LATS2 Kinase Inhibitors for Use in Regenerative Medicine

LATS1和LATS2激酶抑制剂的发现和优化及其在再生医学中的应用

Morris, Patrick J; Duveau, Damien Y; Ceribelli, Michele; Tosto, Frances Anne; Love, Dara N; Scherer, Bridget S; Tao, Dingyin; Fang, Yuhong; Evsen, Lale; Kotler, Samuel A; LeClair, Christopher A; Rai, Ganesha; Thomas, Craig J; Hoyt, Scott B

An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors

对几种布鲁顿酪氨酸激酶(BTK)抑制剂的激酶选择性、酶抑制动力学和体外活性进行评估

Corrionero, Ana; Zhang, Xiaohu; Alfonso, Patricia; Morris, Patrick J; Klumpp-Thomas, Carleen; Melani, Christopher; McKnight, Crystal; Phelan, James D; Holland, David; Wilson, Kelli; Hoyt, Scott B; Roschewski, Mark; Tonge, Peter J; Wilson, Wyndham; Ceribelli, Michele; Staudt, Louis M; Thomas, Craig J

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers

(2R,6R)-羟基去甲氯胺酮在健康志愿者中的安全性、耐受性、药代动力学和药效学的I期评估

Raja, Shruti M; Guptill, Jeffrey T; Mack, Michelle; Peterson, Marni; Byard, Stephen; Twieg, Robert; Jordan, Lynn; Rich, Natalie; Castledine, Richard; Bourne, Samuel; Wilmshurst, Martin; Oxendine, Sarah; Avula, Satya G C; Zuleta, Helen; Quigley, Paul; Lawson, Sheila; McQuaker, Stephen J; Ahmadkhaniha, Reza; Appelbaum, Lawrence G; Kowalski, Kevin; Barksdale, Chineta T; Gufford, Brandon T; Awan, Asaad; Sancho, Alfredo R; Moore, Max C; Berrada, Karim; Cogan, Gregory B; DeLaRosa, Jesse; Radcliffe, Jeanne; Pao, Maryland; Kennedy, Michelle; Lawrence, Quentin; Goldfeder, Lisa; Amanfo, Leslie; Zanos, Panos; Gilbert, Jessica R; Morris, Patrick J; Moaddel, Ruin; Gould, Todd D; Zarate, Carlos A Jr; Thomas, Craig J

Time will tell. Reply to "Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al." by Chen et al

时间会证明一切。回复 Chen 等人对 Jordi Bonaventura 等人“关于氯胺酮对映体药理学和行为学差异的评论”的评论。

Bonaventura, Jordi; Lam, Sherry; Carlton, Meghan; Boehm, Matthew; Gomez, Juan L; Solís, Oscar; Sánchez-Soto, Marta; Morris, Patrick J; Fredriksson, Ida; Thomas, Craig J; Sibley, David R; Shaham, Yavin; Zarate, Carlos A Jr; Michaelides, Michael

Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration

对服用抗抑郁剂量氯胺酮后,人类血浆和脑脊液以及小鼠血浆和脑组织中的代谢组学进行比较分析

Moaddel, Ruin; Zanos, Panos; Farmer, Cristan A; Kadriu, Bashkim; Morris, Patrick J; Lovett, Jacqueline; Acevedo-Diaz, Elia E; Cavanaugh, Grace W; Yuan, Peixiong; Yavi, Mani; Thomas, Craig J; Park, Lawrence T; Ferrucci, Luigi; Gould, Todd D; Zarate, Carlos A Jr

Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications

羟去甲氯胺酮:药理学和潜在治疗应用

Highland, Jaclyn N; Zanos, Panos; Riggs, Lace M; Georgiou, Polymnia; Clark, Sarah M; Morris, Patrick J; Moaddel, Ruin; Thomas, Craig J; Zarate, Carlos A Jr; Pereira, Edna F R; Gould, Todd D

(18)F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography

(18)F标记放射性示踪剂用于正电子发射断层扫描对DREADD进行体内成像

Hu, Feng; Morris, Patrick J; Bonaventura, Jordi; Fan, Hong; Mathews, William B; Holt, Daniel P; Lam, Sherry; Boehm, Matthew; Dannals, Robert F; Pomper, Martin G; Michaelides, Michael; Horti, Andrew G

Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo.

口服有效药物协同组合对抗埃博拉病毒的体内试验的制剂、稳定性、药代动力学和建模研究

Finch Courtney L, Dyall Julie, Xu Shuang, Nelson Elizabeth A, Postnikova Elena, Liang Janie Y, Zhou Huanying, DeWald Lisa Evans, Thomas Craig J, Wang Amy, Xu Xin, Hughes Emma, Morris Patrick J, Mirsalis Jon C, Nguyen Linh H, Arolfo Maria P, Koci Bryan, Holbrook Michael R, Hensley Lisa E, Jahrling Peter B, Schmaljohn Connie, Johansen Lisa M, Olinger Gene G, Schiffer Joshua T, White Judith M

Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening

基于高通量联合药物筛选的弥漫性中线胶质瘤治疗策略

Lin, Grant L; Wilson, Kelli M; Ceribelli, Michele; Stanton, Benjamin Z; Woo, Pamelyn J; Kreimer, Sara; Qin, Elizabeth Y; Zhang, Xiaohu; Lennon, James; Nagaraja, Surya; Morris, Patrick J; Quezada, Michael; Gillespie, Shawn M; Duveau, Damien Y; Michalowski, Aleksandra M; Shinn, Paul; Guha, Rajarshi; Ferrer, Marc; Klumpp-Thomas, Carleen; Michael, Sam; McKnight, Crystal; Minhas, Paras; Itkin, Zina; Raabe, Eric H; Chen, Lu; Ghanem, Reem; Geraghty, Anna C; Ni, Lijun; Andreasson, Katrin I; Vitanza, Nicholas A; Warren, Katherine E; Thomas, Craig J; Monje, Michelle

Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function

抗抑郁药相关浓度的氯胺酮代谢物(2R,6R)-羟基去甲氯胺酮不会阻断NMDA受体功能。

Lumsden, Eric W; Troppoli, Timothy A; Myers, Scott J; Zanos, Panos; Aracava, Yasco; Kehr, Jan; Lovett, Jacqueline; Kim, Sukhan; Wang, Fu-Hua; Schmidt, Staffan; Jenne, Carleigh E; Yuan, Peixiong; Morris, Patrick J; Thomas, Craig J; Zarate, Carlos A Jr; Moaddel, Ruin; Traynelis, Stephen F; Pereira, Edna F R; Thompson, Scott M; Albuquerque, Edson X; Gould, Todd D